Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients

Background: The 21-gene recurrence score (RS) assay has been proven prognostic and predictive for hormone receptor-positive/HER2-negative, node-negative early breast cancer patients. However, whether primary 21-gene RS can predict prognosis in recurrent breast cancer patients remained unknown. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yujie, Tong, Yiwei, Huang, Jiahui, Lin, Lin, Wu, Jiayi, Fei, Xiaochun, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412719/
https://www.ncbi.nlm.nih.gov/pubmed/32850415
http://dx.doi.org/10.3389/fonc.2020.01315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412719/
https://www.ncbi.nlm.nih.gov/pubmed/32850415
http://dx.doi.org/10.3389/fonc.2020.01315

Ejemplares similares